Results 11 to 20 of about 10,634,853 (332)
Emerging and Re-emerging Vector-Borne Infectious Diseases and the Challenges for Control: A Review
Vector-borne emerging and re-emerging diseases pose considerable public health problem worldwide. Some of these diseases are emerging and/or re-emerging at increasing rates and appeared in new regions in the past two decades.
Bayissa Chala, Feyissa Hamde
doaj +2 more sources
Thanks to authors, reviewers and readers [PDF]
By the end of year 2022, Microbes and Infectious Diseases has been indexed in 3 prestigious international platform/database sites, namely EBSCO Periodicals, African Journals OnLine (AJOL), and Directory of Open Access Journals (DOAJ).
Microbes and Infectious Diseases Editorial Board Members
doaj +1 more source
Background There are many pharmacologic therapies that are being used or considered for treatment of coronavirus disease 2019 (COVID-19), with rapidly changing efficacy and safety evidence from trials.
A. Bhimraj+16 more
semanticscholar +1 more source
BACKGROUND The Infectious Diseases Society of America (IDSA) is committed to providing up-to-date guidance on the treatment of antimicrobial-resistant infections.
P. Tamma+5 more
semanticscholar +1 more source
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Over the past several decades, messenger RNA (mRNA) vaccines have progressed from a scepticism-inducing idea to clinical reality. In 2020, the COVID-19 pandemic catalysed the most rapid vaccine development in history, with mRNA vaccines at the forefront ...
Namit Chaudhary+2 more
semanticscholar +1 more source
Guideline for imaging diagnosis of novel coronavirus (2019-ncov) infected pneumonia (1st edition 2020) [PDF]
Without the.
People's medical publishing House+10 more
doaj +1 more source
This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI.
Stuart Johnson+6 more
semanticscholar +1 more source
. The prevention and treatment of COVID-19 nationwide has entered a tackling phase. Effective treatment of severe and critically ill patients is the key to reducing the fatality of the disease.
National Clinical Research Center for Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases⊠ van der Veen
doaj +1 more source
DOI 10.1093/ajhp/zxaa036 Michael J. Rybak, PharmD, MPH, PhD, FCCP, FIDP, FIDSA, Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy & Health Sciences, Wayne State University, Detroit, MI, School of ...
M. Rybak+12 more
semanticscholar +1 more source